282 related articles for article (PubMed ID: 14704738)
1. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation.
Moller DE; Berger JP
Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S17-21. PubMed ID: 14704738
[TBL] [Abstract][Full Text] [Related]
2. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
3. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
Rangwala SM; Lazar MA
Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
[TBL] [Abstract][Full Text] [Related]
5. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma.
Alleva DG; Johnson EB; Lio FM; Boehme SA; Conlon PJ; Crowe PD
J Leukoc Biol; 2002 Apr; 71(4):677-85. PubMed ID: 11927655
[TBL] [Abstract][Full Text] [Related]
6. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect.
Trifilieff A; Bench A; Hanley M; Bayley D; Campbell E; Whittaker P
Br J Pharmacol; 2003 May; 139(1):163-71. PubMed ID: 12746235
[TBL] [Abstract][Full Text] [Related]
7. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.
Ferré P
Diabetes; 2004 Feb; 53 Suppl 1():S43-50. PubMed ID: 14749265
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
[TBL] [Abstract][Full Text] [Related]
9. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors and the control of inflammation.
Cabrero A; Laguna JC; Vázquez M
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
[TBL] [Abstract][Full Text] [Related]
11. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
Panunti B; Fonseca V
Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
[TBL] [Abstract][Full Text] [Related]
12. PPAR alpha, fibrates, lipid metabolism and inflammation.
Duval C; Fruchart JC; Staels B
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation.
Ye JM; Doyle PJ; Iglesias MA; Watson DG; Cooney GJ; Kraegen EW
Diabetes; 2001 Feb; 50(2):411-7. PubMed ID: 11272155
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma and metabolic disease.
Willson TM; Lambert MH; Kliewer SA
Annu Rev Biochem; 2001; 70():341-67. PubMed ID: 11395411
[TBL] [Abstract][Full Text] [Related]
15. PPARs and the complex journey to obesity.
Evans RM; Barish GD; Wang YX
Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233
[TBL] [Abstract][Full Text] [Related]
16. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
Uauy R; Martínez JI; Rojas CV
Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
[TBL] [Abstract][Full Text] [Related]
17. The mechanisms of action of PPARs.
Berger J; Moller DE
Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
[TBL] [Abstract][Full Text] [Related]
18. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
[TBL] [Abstract][Full Text] [Related]
19. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
[TBL] [Abstract][Full Text] [Related]
20. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
Andrééva-Gatéva P
Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]